Cao JZ - Search Results

1

Radiotherapy is essential after complete response to asparaginase-containing chemotherapy in early-stage extranodal nasal-type NK/T-cell lymphoma: A multicenter study from the China Lymphoma Collaborative Group (CLCG).

Deng XW, Wu JX, Wu T, Zhu SY, Shi M, Su H, Wang Y, He X, Xu LM, Yuan ZY, Zhang LL, Wu G, Qu BL, Qian LT, Hou XR, Zhang FQ, Zhang YJ, Zhu Y, Cao JZ, Lan SM, Dong M, Qi SN, Yang Y, Li YX. Deng XW, et al. Among authors: cao jz. Radiother Oncol. 2018 Oct;129(1):3-9. doi: 10.1016/j.radonc.2018.04.026. Epub 2018 May 5. Radiother Oncol. 2018. PMID: 29739712

2

Randomized phase II study of concurrent cisplatin/etoposide or paclitaxel/carboplatin and thoracic radiotherapy in patients with stage III non-small cell lung cancer.

Wang L, Wu S, Ou G, Bi N, Li W, Ren H, Cao J, Liang J, Li J, Zhou Z, Lv J, Zhang X. Wang L, et al. Lung Cancer. 2012 Jul;77(1):89-96. doi: 10.1016/j.lungcan.2012.02.011. Epub 2012 Mar 13. Lung Cancer. 2012. PMID: 22418243 Clinical Trial.

3

Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study.

Yang Y, Zhu Y, Cao JZ, Zhang YJ, Xu LM, Yuan ZY, Wu JX, Wang W, Wu T, Lu B, Zhu SY, Qian LT, Zhang FQ, Hou XR, Li YX. Yang Y, et al. Among authors: cao jz. Blood. 2015 Sep 17;126(12):1424-32; quiz 1517. doi: 10.1182/blood-2015-04-639336. Epub 2015 Jun 24. Blood. 2015. PMID: 26109206 Free article.

4

[The predictive value of Ki-67 expression for prognosis in patients with extranodal nasal type NK/T-cell lymphoma].

Cao J, Zhang N, Liang Y, Liu B, Guo R, Li H, Lan S. Cao J, et al. Zhonghua Xue Ye Xue Za Zhi. 2015 Jul;36(7):612-4. doi: 10.3760/cma.j.issn.0253-2727.2015.07.019. Zhonghua Xue Ye Xue Za Zhi. 2015. PMID: 26304090 Free PMC article. Chinese. No abstract available.

5

Association of Improved Locoregional Control With Prolonged Survival in Early-Stage Extranodal Nasal-Type Natural Killer/T-Cell Lymphoma.

Yang Y, Cao JZ, Lan SM, Wu JX, Wu T, Zhu SY, Qian LT, Hou XR, Zhang FQ, Zhang YJ, Zhu Y, Xu LM, Yuan ZY, Qi SN, Li YX. Yang Y, et al. Among authors: cao jz. JAMA Oncol. 2017 Jan 1;3(1):83-91. doi: 10.1001/jamaoncol.2016.5094. JAMA Oncol. 2017. PMID: 27893001

6

A comparison of treatment modalities for nasal extranodal natural killer/T-cell lymphoma in early stages: The efficacy of CHOP regimen based concurrent chemoradiotherapy.

Cao J, Lan S, Shen L, Si H, Zhang N, Li H, Guo R. Cao J, et al. Oncotarget. 2017 Mar 21;8(12):20362-20370. doi: 10.18632/oncotarget.13614. Oncotarget. 2017. PMID: 27901491 Free PMC article.

7

Assessment of prognostic scores of brain metastases from lung adenocarcinoma with EGFR mutations.

Li H, Lian J, Jin H, Wang W, Cao J, Zhang X, Song X, Jia S, Jia H, Ren J, Han S, Yang W, Xi Y, Lan S. Li H, et al. J Neurooncol. 2017 May;133(1):129-135. doi: 10.1007/s11060-017-2411-2. Epub 2017 Apr 8. J Neurooncol. 2017. PMID: 28391386

8

Hemoglobin level, a prognostic factor for nasal extranodal natural killer/T-cell lymphoma patients from stage I to IV: A validated prognostic nomogram.

Cao J, Lan S, Shen L, Si H, Xiao H, Yuan Q, Li X, Li H, Guo R. Cao J, et al. Sci Rep. 2017 Sep 8;7(1):10982. doi: 10.1038/s41598-017-11137-9. Sci Rep. 2017. PMID: 28887511 Free PMC article.

9

Applicability of graded prognostic assessment of lung cancer using molecular markers to lung adenocarcinoma patients with brain metastases.

Li H, Lian J, Han S, Wang W, Jia H, Cao J, Zhang X, Song X, Jia S, Ren J, Yang W, Xi Y, Lan S. Li H, et al. Oncotarget. 2017 Aug 7;8(41):70727-70735. doi: 10.18632/oncotarget.19980. eCollection 2017 Sep 19. Oncotarget. 2017. PMID: 29050314 Free PMC article.

10

Risk-adapted survival benefit of IMRT in early-stage NKTCL: a multicenter study from the China Lymphoma Collaborative Group.

Wu T, Yang Y, Zhu SY, Shi M, Su H, Wang Y, He X, Xu LM, Yuan ZY, Zhang LL, Wu G, Qu BL, Qian LT, Hou XR, Zhang FQ, Zhang YJ, Zhu Y, Cao JZ, Lan SM, Wu JX, Hu C, Qi SN, Chen B, Li YX. Wu T, et al. Among authors: cao jz. Blood Adv. 2018 Sep 25;2(18):2369-2377. doi: 10.1182/bloodadvances.2018021311. Blood Adv. 2018. PMID: 30242098 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

146 results

Search Page

Filters